None
EN
Comment on How patient-led research could speed up medical innovation by Nicotine patches help relieve symptoms in some people with Long COVID. Can the science behind it lead to future therapies? - The Sick Times
['Betsy Ladyzhets', 'Betsy Ladyzhets Is A Co-Founder', 'The Managing Editor Of The Sick Times.', 'David Tuller', 'Madelleine Muller', 'Miles W. Griffis', '.Wp-Block-Post-Author Box-Sizing Border-Box Display Flex Flex-Wrap Wrap .Wp-Block-Post-Author__Byline Font-Size Margin-Bottom Margin-Top Width', '.Wp-Block-Post-Author__Avatar Margin-Right .Wp-Block-Post-Author__Bio Font-Size Margin-Bottom .Wp-Block-Post-Author__Content Flex-Basis Flex-Grow .Wp-Block-Post-Author__Name Margin', 'Sourceurl Https', 'Thesicktimes.Org Wp-Content Plugins Gutenberg Build Styles Block-Library Post-Author Style.Min.Css']
Comments for The Sick Times
It’s a research project started in early 2023 by Tamara Romanuk and Tess Falor, two people with myalgic encephalomyelitis/chronic fatigue syndrome, or ME/CFS, a chronic disease that shares symptoms with long COVID. Result: Remission Biome members hope to experience some symptom relief, as well as publish study findings and inspire new research projects for professional scientists. For example, feedback from members of Remission Biome and other patient representatives helped David Esteban, a biologist at Vassar College in Poughkeepsie, N.Y., who was looking for people who had gotten COVID-19 but didn’t develop long COVID and could serve as control patients in a project funded by PLRC.